Skyepharma is a leader in drug development and delivery of oral technologies serving the global pharmaceutical, biotech, and consumer health industries.
Our controlled-release technologies and oral solids capability offer :
■ Manufacturing services for oral solid tablets, as well as powders, pellets, beads, and granules
As per our R&D experience and our industrial capabilities, we know what it takes to bring successful therapies to market, and we are excited to bring this expertise to our customers.
Skyepharma has many years of experience in working with their partners in the development and manufacturing of complex oral dosage forms, as part of a planned Life Cycle Management strategy. The outcome is 10 different oral products currently marketed by multinational pharmaceutical companies in numerous countries worldwide.
Our highly experienced team of specialists can work with you to optimise your target product profile and your drug development program from early formulation development, scale-up and manufacturing to regulatory support, and to reduce your time to market.
We maximise mutual companies growth opportunities and optimise our value through the creation of alliance teams ensuring the right understanding of customer key objectives and strategy :